Japan’s government has highlighted Artificial Intelligence as a way to take on various challenges in the society including the healthcare industry. How to reduce increasing healthcare costs and transform the healthcare delivery to provide better outcomes are two major concerns. Major technology companies such as NEC and Fujitsu are utilising AI focusing on new approaches to diagnostics and drug discovery. Several start-ups are active developing AI-based applications for medical imaging and hospital workflow. AI is positioned as a priority technology that could offer business opportunities for EU companies with unique, attractive applications.
The webinar is targeted to EU companies seeking to learn more about the Japanese medical sector and its status in terms of utilisation of Artificial Intelligence.
Registration deadline: 08/06/2020
In 40 minutes from your desk, discover how to:
Programme:
Speaker: Maths Lundin (Sweden Japan Consulting).
Moderator: Gwenael Beauvais - Business Support Coordinator, EU-Japan Centre for Industrial Cooperation
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026